GlassScriptPhysician profile
Michael Nooromid
NPI 1760827497
$32,830.33
in general payments reported to CMS, 2019-2025
21 companies · $4,586 in 2025
The $4,586 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $763 · 2021: $902 · 2022: $1,290 · 2023: $3,613 · 2024: $11K · 2025: $4,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,460 · Food and Beverage: $6,204 · Consulting Fee: $2,850 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,459.96 |
| Food and Beverage | $6,203.50 |
| Consulting Fee | $2,850.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,540.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $10,884.12 | 2019-2020 | |
| Medtronic, INC. | $8,708.21 | 2021-2025 | Hawkone, Ellipsys Vascular Access System, Abre |
| Endologix LLC | $3,817.62 | 2021-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System, Torus Stent Graft System |
| Cook Medical LLC | $3,056.01 | 2021-2025 | Cook, Zenith Spiral-Z, Zenith Flex |
| Penumbra, INC. | $1,928.18 | 2024-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $1,156.57 | 2023-2025 | Gore Tag Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| C. R. Bard, INC. & Subsidiaries | $700.00 | 2020 | |
| Becton, Dickinson and Company | $529.02 | 2021-2024 | |
| Shockwave Medical, INC | $466.84 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $460.98 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $293.69 | 2023-2025 | Eluvia |
| Aroa Biosurgery Incorporated | $178.35 | 2022 | |
| Bolton Medical INC | $171.14 | 2023-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Siemens Medical Solutions USA, INC. | $165.19 | 2023 | Naeotom Alpha |
| Philips North America LLC | $142.00 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $42.33 | 2024-2025 | Stratafix, Ethicon |
| Cardiovascular Systems INC. | $34.26 | 2022 | |
| Baxter Healthcare | $33.34 | 2025 | Seprafilm |
| Bard Peripheral Vascular, INC. | $30.17 | 2023 | |
| Atricure, INC. | $17.27 | 2021 | |
| Surmodics, INC. | $15.04 | 2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nooromid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.